Effect of Trumenba on Gonococcal Infections in Adolescents and Young Adults in the United States: A Retrospective Cohort Study
Status: Completed
Location: See location...
Intervention Type: Biological
Study Type: Observational
SUMMARY
Brief Summary: The main purpose of the study is to learn about how well Trumenba vaccine shot works against gonorrhea infection. This study looks at data records from a database in the United States. This study includes patient's data from the database who: * Are 15-30 years old. * Have received at least one dose of Trumenba and a MenACWY vaccine or who have received only MenACWY vaccine. This data has already been collected in the past and is being studied between April and June of 2023.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 15
Maximum Age: 30
Healthy Volunteers: f
View:
• Individuals of 15-30 years old registered in the PharMetrics Plus system
• Individuals having the index vaccination event at the age of 15-30 in 2016-2021
Locations
United States
New York
Pfizer
New York
Time Frame
Start Date: 2023-04-24
Completion Date: 2024-03-31
Participants
Target number of participants: 1307378
Treatments
Trumenba +MenACWY Vaccinated
Exposure Cohort that received at least one dose of Trumenba and MenACWY vaccine
MenACWY Only Vaccinated
Non-exposure (reference cohort) that received at least one dose of MenACWY vaccine and no Trumenba vaccine.
Sponsors
Leads: Pfizer